Sanofi (SNY) Change in Cash (2013 - 2026)

Sanofi has disclosed Change in Cash across 7 years of filings, most recently posting -$2.5 billion for Q1 2026.

• Change in Cash for Q1 2026 came in at -$2.5 billion, down 527.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.1 billion (down 9.04% YoY), and the FY2025 annual result was $251.4 million, up 118.54% from the prior year.
• Change in Cash came in at -$2.5 billion for Q1 2026 at Sanofi, up from -$10.7 billion in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $8.3 billion in Q2 2025 to a low of -$10.7 billion in Q4 2025.
• The 3-year median for Change in Cash is -$422.2 million (2024), against an average of -$740.9 million.
• Peak annual rise in Change in Cash reached 424.59% in 2025, while the deepest fall reached 686.9% in 2025.
• Sanofi's Change in Cash stood at -$1.4 billion in 2024, then plunged by 686.9% to -$10.7 billion in 2025, then surged by 76.82% to -$2.5 billion in 2026.
• The last three Change in Cash figures came in at -$2.5 billion (Q1 2026), -$10.7 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.